Liabilities / Assets
55th percentile
Tied with the lowest-debt nonprofits in its peer group.
990 • Fiscal year 2020 • EIN 46-5662435
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
55th percentile
Tied with the lowest-debt nonprofits in its peer group.
Liabilities / Revenue
55th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
97th percentile
Higher net margin than 97% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
98th percentile
Faster asset growth than 98% of similar nonprofits.
Revenue Growth
99th percentile
Faster revenue growth than 99% of similar nonprofits.
Assets
Up$234,542
Up $216,689 (+1214%) from 2019
Net Assets
$234,542
No earlier filing loaded for comparison.
Liabilities
Flat$0
Flat from 2019
Revenue
Up$243,145
Up $221,319 (+1014%) from 2019
Expenses
Up$26,456
Up $7,501 (+40%) from 2019
Net Income
Up$216,689
Up $213,818 (+7448%) from 2019
This 2020 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
We are a rare disease patient advocacy organization. Our mission is to support medical research that will lead to safe and effective treatments for individuals with Snyder-Robinson Syndrome and related disorders; and for related scientific and charitable purposes.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2020 • Form 990Summary only. Only limited summary data is available for this year.